Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

INTRODUCTION: Insulin degludec is a new, ultra-long-acting basal insulin. The aim of this study was to analyze the changes of basal insulin dose and blood glucose profile in basal–bolus therapy of type 1 diabetes mellitus (T1DM) at the switching of basal insulin from insulin glargine or detemir to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusunoki, Yoshiki, Katsuno, Tomoyuki, Miyakoshi, Kana, Ikawa, Takashi, Nakae, Rie, Ochi, Fumihiro, Tokuda, Masaru, Akagami, Takafumi, Murai, Kazuki, Miuchi, Masayuki, Hamaguchi, Tomoya, Miyagawa, Jun-ichiro, Namba, Mitsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889322/
https://www.ncbi.nlm.nih.gov/pubmed/24282104
http://dx.doi.org/10.1007/s13300-013-0048-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889322/
https://www.ncbi.nlm.nih.gov/pubmed/24282104
http://dx.doi.org/10.1007/s13300-013-0048-5

Ejemplares similares